These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29301007)

  • 1. Low Birth Weight in Human Immunodeficiency Virus-Exposed Uninfected Infants in Bronx, New York.
    Dara JS; Hanna DB; Anastos K; Wright R; Herold BC
    J Pediatric Infect Dis Soc; 2018 May; 7(2):e24-e29. PubMed ID: 29301007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
    Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.
    Williams PL; Marino M; Malee K; Brogly S; Hughes MD; Mofenson LM;
    Pediatrics; 2010 Feb; 125(2):e250-60. PubMed ID: 20083530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between HIV in pregnancy and antiretroviral therapy, including protease inhibitors and low birth weight infants.
    Goldstein PJ; Smit R; Stevens M; Sever JL
    Infect Dis Obstet Gynecol; 2000; 8(2):94-8. PubMed ID: 10805364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 6-week PMTCT outcomes for HIV-exposed and HIV-unexposed infants in the era of lifelong ART: Results from an observational prospective cohort study.
    Tiam A; Kassaye SG; Machekano R; Tukei V; Gill MM; Mokone M; Letsie M; Tsietso M; Seipati I; Barasa J; Isavwa A; Tylleskär T; Guay L
    PLoS One; 2019; 14(12):e0226339. PubMed ID: 31877153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy.
    Gantt S; Leister E; Jacobsen DL; Boucoiran I; Huang ML; Jerome KR; Jourdain G; Ngo-Giang-Huong N; Burchett S; Frenkel L
    J Med Virol; 2016 Jun; 88(6):1051-8. PubMed ID: 26519647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.
    Szyld EG; Warley EM; Freimanis L; Gonin R; Cahn PE; Calvet GA; Duarte G; Melo VH; Read JS;
    AIDS; 2006 Nov; 20(18):2345-53. PubMed ID: 17117021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower birth weight-for-age and length-for-age z-scores in infants with in-utero HIV and ART exposure: a prospective study in Cape Town, South Africa.
    Nyemba DC; Kalk E; Madlala HP; Malaba TR; Slogrove AL; Davies MA; Boulle A; Myer L; Powis KM
    BMC Pregnancy Childbirth; 2021 May; 21(1):354. PubMed ID: 33947351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants.
    Frederick T; Homans J; Spencer L; Kramer F; Stek A; Operskalski E; Kovacs A
    Clin Infect Dis; 2012 Sep; 55(6):877-84. PubMed ID: 22675157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.
    Abrams EJ; Matheson PB; Thomas PA; Thea DM; Krasinski K; Lambert G; Shaffer N; Bamji M; Hutson D; Grimm K
    Pediatrics; 1995 Sep; 96(3 Pt 1):451-8. PubMed ID: 7651777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination antiretroviral use and preterm birth.
    Watts DH; Williams PL; Kacanek D; Griner R; Rich K; Hazra R; Mofenson LM; Mendez HA;
    J Infect Dis; 2013 Feb; 207(4):612-21. PubMed ID: 23204173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother-Infant Pairs During the Transition From Option A to Option B+ in Zimbabwe.
    Dinh TH; Mushavi A; Shiraishi RW; Tippett Barr B; Balachandra S; Shambira G; Nyakura J; Zinyowera S; Tshimanga M; Mugurungi O; Kilmarx PH
    Clin Infect Dis; 2018 Feb; 66(4):576-585. PubMed ID: 29401270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal Tenofovir Disoproxil Fumarate Use in Pregnancy and Growth Outcomes among HIV-Exposed Uninfected Infants in Kenya.
    Pintye J; Langat A; Singa B; Kinuthia J; Odeny B; Katana A; Nganga L; John-Stewart G; McGrath CJ
    Infect Dis Obstet Gynecol; 2015; 2015():276851. PubMed ID: 26823647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe.
    Newell ML; Borja MC; Peckham C;
    Pediatrics; 2003 Jan; 111(1):e52-60. PubMed ID: 12509595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects in children exposed to maternal HIV and antiretroviral therapy during pregnancy in Brazil: a cohort study.
    Delicio AM; Lajos GJ; Amaral E; Cavichiolli F; Polydoro M; Milanez H
    Reprod Health; 2018 May; 15(1):76. PubMed ID: 29747664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero.
    Ajaykumar A; Zhu M; Kakkar F; Brophy J; Bitnun A; Alimenti A; Soudeyns H; Saberi S; Albert AYK; Money DM; Côté HCF;
    J Infect Dis; 2021 Feb; 223(4):621-631. PubMed ID: 32638023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age.
    Snijdewind IJM; Smit C; Godfried MH; Bakker R; Nellen JFJB; Jaddoe VWV; van Leeuwen E; Reiss P; Steegers EAP; van der Ende ME
    PLoS One; 2018; 13(1):e0191389. PubMed ID: 29351561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of maternal HIV status and treatment duration on body composition of HIV-exposed and HIV-unexposed preterm, very and extremely low-birthweight infants.
    Strydom K; Nel DG; Dhansay MA; Van Niekerk E
    Paediatr Int Child Health; 2018 Aug; 38(3):163-174. PubMed ID: 29790827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.